Subject(s)
Complement C3a/genetics , Coronary Disease/genetics , Genetic Predisposition to Disease , Triglycerides/blood , Female , Humans , MaleABSTRACT
The aim of this study was to investigate the N-terminal brain natriuretic peptide precursor (NT-proBNP) levels in the peripheral blood of patients with acute coronary syndrome (ACS) and to provide the basis for its application in the early diagnosis of ACS. A total of 440 patients admitted to the hospital for examination and treatment were enrolled, including 330 patients with ACS and 110 cases in the control group. Routine blood examination and determination of NT-proBNP in all subjects were conducted immediately at the time of admission to analyze the difference in plasma NT-proBNP between the two groups. The plasma NT-proBNP levels in ACS were significantly higher (P < 0.01) and were associated with the severity of coronary lesions. The present study indicated that the plasma NT-proBNP level in ACS patients is significantly increased and has a potential value in the early diagnosis of ACS.
Subject(s)
Acute Coronary Syndrome/blood , Acute Coronary Syndrome/diagnosis , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Aged , Case-Control Studies , Electrocardiography , Female , Humans , Male , Middle Aged , Risk Factors , Severity of Illness IndexABSTRACT
This study was designed to analyze the relationship between serum creatinine and body mass index in children in Xinjiang, China. We used a stratified sampling method to select 5222 children aged 6-17 years in 3 areas in Xinjiang and then measured serum creatinine with an enzymatic method. Our analysis showed that the mean serum creatinine of the various age groups differed, and the reference value increased gradually with age. In the groups with subjects older than 10 years, the serum creatinine values had a positive correlation with body mass index (r = 0.016, 10- and 11-year-olds; r = 0.177, 12- and 13-year-olds; r = 0.314, 14- and 15-year-olds; r = 0.380, 16- and 17-year-olds; P < 0.05). In the multivariate regression analysis model, the positive relationship existed even after we removed influencing factors such as blood sugar and cholesterol (ß = 0.041, 10- and 11-year-olds; ß = 0.081, 12- and 13-year-olds; ß = 0.183, 14- and 15-year-olds; ß = 0.171, 16- and 17-year-olds; P < 0.05). Obesity is an independent risk factor associated with increasing serum creatinine levels in children aged more than 10 years. Weight control is important in the protection of renal function.
Subject(s)
Creatinine/blood , Obesity/blood , Adolescent , Body Composition , Body Mass Index , Child , China , Female , Humans , Male , Obesity/pathology , Risk FactorsABSTRACT
The association of the single nucleotide polymorphism 301T>C in the coding region of the acylation-stimulating protein (ASP) gene with coronary heart disease (CHD) was investigated in the Uygur (385 CHD patients and 483 control subjects) and Han (390 CHD patients and 439 control subjects) populations of China. The frequency of the CC and CT genotypes was significantly higher in patients with CHD compared to the control group (55.3 vs 46.2%, P = 0.001) in the Uygur population, but in the Han population, the frequency was significantly higher in the control group (51.7 vs 24.4%, P < 0.001). In addition, the C allele was significantly associated with CHD in the Uygur population (C allele: 33.8 vs 26.2%, T allele: 66.2 vs 73.8%; P = 0.004) and in the Han population (C allele: 14.5 vs 30.3%, T allele: 85.5 vs 69.7%; P < 0.001). The CC genotype was independently associated with increased risk of coronary artery disease when adjusted for other cardiovascular risk factors [odds ratio (OR) = 2.189, 95% confidence interval (CI) = 1.251-3.830, P = 0.001] in the Uygur population, but was a protective factor for CHD in the Han population (OR = 0.373, 95%CI = 0.187-0.745, P = 0.005). In conclusion, the 301T>C polymorphism of the ASP gene that influences the serum triglycerides level in the Uygur population, is associated with the development of CHD, and the CC genotype might be a risk factor of CHD.
Subject(s)
Complement C3a/genetics , Coronary Disease/genetics , Genetic Predisposition to Disease , Triglycerides/blood , Acylation/genetics , Aged , Asian People/genetics , China , Coronary Disease/blood , Female , Gene Frequency , Genetic Association Studies , Humans , Male , Middle Aged , Polymorphism, Single NucleotideABSTRACT
This study was designed to estimate the prevalence of diabetes and impaired fasting glucose (IFG) in Xinjiang children in western China. Data were obtained from the Chun-Miao Project, a community-based, cross-sectional study designed to investigate the prevalence and risk factors of diabetes in children of the Chinese Uygur population in Xinjiang from February 2010 to May 2012. A total of 3644 children completed the survey and measurements of fasting glucose. Diabetes and IFG were defined using American Diabetes Association 2009 criteria. Overall, 0.7% of the 3644 Uygur children had IFG and 0.1% had diabetes. In the newborn to 8-year-old group, the prevalence of diabetes and IFG was 0.6 and 1.1%, respectively. In the 9-13-year-old group, the prevalence of diabetes and IFG was 0.1 and 0.7%, respectively. There was no evidence of IFG or diabetes in the 14-17-year-old group. Logistic regression analysis suggested that overweight and obesity were independent risk factors of diabetes in Uygur children of Xinjiang. The prevalence of diabetes and IFG in Uygur children was lower than that reported previously in children of other ethnicities in China.
Subject(s)
Blood Glucose , Diabetes Mellitus/blood , Diabetes Mellitus/epidemiology , Adolescent , Child , Child, Preschool , China/epidemiology , China/ethnology , Cross-Sectional Studies , Ethnicity , Fasting , Female , Humans , Infant , Infant, Newborn , Male , Prevalence , Public Health Surveillance , Risk FactorsABSTRACT
Extracellular signal-regulated kinase (ERK1/2) is one of the mitogen-activated protein kinases, key components of the reperfusion injury salvage kinase pathway, which plays an important role in protecting the myocardium from lethal ischemia-reperfusion injury. Constitutive activation of the mitogen-activated protein kinase kinase 1 (CaMEK) can promote ERK1/2 expression, which is thereby expected to exert protective action on the heart against ischemia-reperfusion injury. The adeno-associated virus serotype 9 vector (AVV9) is a novel tool for gene therapies targeting human diseases owing to its nonpathogenic capability for transducing nondividing cells and its long-term transgene expression. We used a recombinant AAV9 vector to deliver the CaMEK gene into cardiomyocytes and assessed whether AAV9 vector-mediated CaMEK gene transfection could enhance the long-term expression and activity of ERK1/2. Our observations suggest that AAV9-mediated gene expression is preferentially restricted to cardiomyocytes and that mediated CaMEK gene transfection enhanced the expression of ERK1/2 phosphorylation and consequently upregulated the expression of downstream components of ERK1/2 and its transcription factors.
Subject(s)
Dependovirus/genetics , MAP Kinase Kinase 1/genetics , MAP Kinase Signaling System , Myocytes, Cardiac/metabolism , Animals , Cells, Cultured , Gene Expression , Genetic Therapy , Genetic Vectors , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , MAP Kinase Kinase 1/metabolism , Phosphorylation , Primary Cell Culture , Protein Processing, Post-Translational , Rats , Rats, Sprague-Dawley , Transcription Factors/metabolism , Transduction, GeneticABSTRACT
C5L2, a G protein-coupled receptor, is known to be a functional receptor of acylation-stimulating protein, which is a stimulator of triglyceride synthesis and glucose transport. A novel C5L2 variant (S323I) was identified and its association with familial combined hyperlipidemia (FCH) was recently reported. We looked for this SNP in three Chinese ethnic groups, including Han, Uygur, and Kazakh controls and patients with FCH and type 2 diabetes. One hundred and eighty-two unrelated subjects (77 of Han, 57 of Uygur, and 48 of Kazakh) with FCH were genotyped by direct sequencing, and 852 subjects (342 of Han, 338 of Uygur, 172 of Kazakh) with type 2 diabetes and 200 healthy controls (67 of Han, 72 of Uygur, and 61 of Kazakh) chosen from a cardiovascular risk survey study were genotyped with PCR-RFLP analysis. All 182 subjects with FCH, 99.5% of the type 2 diabetes patients and 100% of the healthy controls were successfully genotyped. Neither the FCH subjects nor the type 2 diabetes patients were found to have the S323I variant. This variant was also not identified in the healthy controls. We found no evidence to demonstrate that the S323I polymorphism contributes to familial combined hyperlipidemia or type 2 diabetes in the Chinese population.